 CAMBRIDGE, Mass. and NEW YORK, Feb. 11, 2021 GLOBE NEWSWIRE -- Black Diamond Therapeutics, Inc. Nasdaq: BDTX, a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present at the BMO Biopharma Spotlight Series on Thursday, February 18, 2021 at 11:50 AM ET. Dr. Epsteins presentation will be featured in the session entitled Company Spotlights: Novel Approaches to Advance Protein Technologies. 